Moderna, BioNTech rise as vaccine advisory panel backs off mRNA vaccine threat
Stocks focused on developing mRNA vaccines, including Moderna (MRNA) and BioNTech (BNTX), are higher in Wednesday trading...
Tag: BNTX
Biontech outlines €2B–€2.3B revenue target for 2026 while advancing late-stage oncology pipeline and leadership transition
Earnings Call Insights: BioNTech SE (BNTX) Q4 2025 CEO Ugur Sahin highlighted that BioNTech maintained its leadership in the...
BioNTech falls on outlook, departure of co-founders
BioNTech (BNTX), the partner of Pfizer (PFE) for the Comirnaty COVID-19 vaccine, fell 18% in the premarket on Tuesday after...
BioNTech Non-GAAP EPS of -€0.33, revenue of €907.4M
BioNTech press release (BNTX): Q4 Non-GAAP EPS of -€0.33. Revenue of €907.4M (-23.7% Y/Y).
BioNTech Q4 2025 Earnings Preview
BioNTech (BNTX) is scheduled to announce Q4 earnings results on Tuesday, March 10th, before market open. The consensus EPS...
CDC advisory meeting in March to focus on COVID-19 vaccine injuries, long COVID
The CDC has added topics on COVID-19 vaccine injuries and long COVID to the agenda of the next meeting of its vaccine...
CDC said to delay vaccine panel meeting after lawsuit challenging its composition
The CDC will delay an upcoming meeting of its vaccine advisory committee to March after a lawsuit challenging recent changes...
Pediatrics group defies CDC, endorses COVID, flu shots for children
The American Academy of Pediatrics updated immunization schedule for children and adolescents recommends the COVID-19 and...
HHS secretary RFK Jr. adds two new members to CDC vaccine panel
Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., on Tuesday named two experts in obstetrics and gynecology...
BioNTech eyes catalyst-rich 2026 as it advances multi-product oncology strategy
BioNTech SE (BNTX) said Monday it will continue executing its strategy in 2026 to evolve into a multi-product oncology...